Search Results - "Olecki, Elizabeth J"

Gastric Cancer Treatments and Survival Trends in the United States by Stahl, Kelly A, Olecki, Elizabeth J, Dixon, Matthew E, Peng, June S, Torres, Madeline B, Gusani, Niraj J, Shen, Chan

“…Gastric cancer is the third most common cause of cancer deaths worldwide. Despite evidence-based recommendation for treatment, the current treatment patterns…”
Get full text

ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients by Olecki, Elizabeth J., Gusani, Niraj J.

Get full text

High-Grade Dysplasia in Inflammatory Bowel Disease: Indication for Colectomy by Olecki, Elizabeth J., Perez Hoguin, Rolfy A., King, Steven, Razavi, Nina C., Scow, Jeffery S.

“…Patients with inflammatory bowel disease have an increased risk of colorectal cancer and are recommended to undergo increased surveillance compared to the…”
Get full text

Stoma-less IPAA Is Not Associated With Increased Anastomotic Leak Rate or Long-term Pouch Failure in Patients With Ulcerative Colitis by Olecki, Elizabeth J., Kronfli, Anthony P., Stahl, Kelly A., King, Steven, C. Razavi, Nina, Koltun, Walter A.

“…There is debate regarding the utility of diverting loop ileostomy with IPAA construction in patients requiring colectomy for ulcerative colitis. This study…”
Get full text

Undertreatment of Pancreatic Cancer: Role of Surgical Pathology by Olecki, Elizabeth J., Stahl, Kelly, Peng, June S., Dixon, Matthew, Gusani, Niraj J., Shen, Chan

“…Background Current guidelines recommend treatment of early-stage pancreatic cancer with surgical resection and chemotherapy. Undertreatment can occur after…”
Get full text

Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology by Olecki, Elizabeth J., Stahl, Kelly A., Torres, Madeline B., Peng, June S., Dixon, Matthew, Shen, Chan, Gusani, Niraj J.

“…Background With limited evidence, the benefit of adjuvant chemotherapy (AT) after completion of neoadjuvant chemotherapy (NT) and surgical resection for…”
Get full text

Survival Benefit of Guideline-Concordant Postoperative Radiation for Local Merkel Cell Carcinoma by Wong, William G., Stahl, Kelly, Olecki, Elizabeth J., Holguin, Rolfy Perez, Pameijer, Colette, Shen, Chan

“…Postoperative radiation therapy (RT) for early-stage Merkel Cell Carcinoma (MCC) decreases the risk of locoregional recurrence and improve overall survival…”
Get full text

Insurance Status and Travel Distance to Single Treatment Facility Predictive of Mastectomy by Stahl, Kelly A., Dodge, Daleela, Olecki, Elizabeth J., Holguin, Rolfy Perez, McLaughlin, Christopher, Wong, William, Shen, Chan

“…•Better survival with breast conserving therapy versus mastectomy in early breast cancer•Longer travel distance is associated with the receipt of mastectomy…”
Get full text

Benefits of Trimodality Therapy Compared with Systemic Therapy Alone in Male Patients with Stage IV Breast Cancer by Stahl, Kelly A., Wong, William, Olecki, Elizabeth J., McLaughlin, Christopher, Perez-Holguin, Rolfy, Lewcun, Joseph A., Dodge, Daleela, Shen, Chan

“…Background Male breast cancer (MBC) represents <1% of all breast cancer (BC) diagnoses. Recent publications in female stage IV BC have shown that surgical…”
Get full text

Outcomes after sublobar resection versus lobectomy in non–small cell carcinoma in situ by Perez Holguin, Rolfy A., Olecki, Elizabeth J., Wong, William G., Stahl, Kelly A., Go, Pauline H., Taylor, Matthew D., Reed, Michael F., Shen, Chan

“…Guidelines for treatment of non–small cell lung cancer identify patients with tumors ≤2 cm and pure carcinoma in situ histology as candidates for sublobar…”
Get full text

Predictors and Outcomes of Minimally Invasive Surgery for Small Bowel Neuroendocrine Tumors: Minimally Invasive Surgery for SBNETs by Wong, William, Perez Holguin, Rolfy A., Olecki, Elizabeth J., Stahl, Kelly A., Dixon, Matthew, Peng, June, Dasari, Arvind, Shen, Chan

“…Background Open surgical resection with regional lymphadenectomy is the standard of care for small bowel neuroendocrine tumors (SBNETs). There is no consensus…”
Get full text

ASO Visual Abstract: Benefits of Trimodality Therapy Compared with Systemic Therapy Alone in Male Patients with Stage IV Breast Cancer by Stahl, Kelly A., Wong, William, Olecki, Elizabeth J., McLaughlin, Christopher, Perez-Holguin, Rolfy, Lewcun, Joseph A., Dodge, Daleela, Shen, Chan

Get full text

Disparities in Surgical Treatment of Resectable Pancreatic Adenocarcinoma at Minority Serving Hospitals by Olecki, Elizabeth J., Perez Holguin, Rolfy A., Mayhew, Mackenzie M., Wong, William G., Vining, Charles C., Peng, June S., Shen, Chan, Dixon, Matthew E.B.

“…Minority serving hospitals (MSH) are those serving a disproportionally high number of minority patients. Previous research has demonstrated that treatment at…”
Get full text

ASO Visual Abstract: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival in Those with Low-Risk Pathology by Olecki, Elizabeth J., Stahl, Kelly A., Torres, Madeline B., Peng, June S., Dixon, Matthew, Shen, Chan, Gusani, Niraj J.

Get full text

Management of Clinical T2N0 Esophageal and Gastroesophageal Junction Adenocarcinoma: What Is the Optimal Treatment? by Perez Holguin, Rolfy A., Olecki, Elizabeth J., Stahl, Kelly A., Wong, William G., Vining, Charles C., Dixon, Matthew E. B., Peng, June S.

“…Background The current standard of care for locally advanced esophageal and gastroesophageal junction (GEJ) adenocarcinoma includes neoadjuvant chemoradiation…”
Get full text

Predictors of Conversion During Minimally Invasive Gastrectomy for Malignancy by Perez Holguin, Rolfy A., Stahl, Kelly A., Hendriksen, Brandon S., Wong, William G., Olecki, Elizabeth J., Vining, Charles C., Dixon, Matthew E., Peng, June S., Shen, Chan

“…INTRODUCTIONImplementation of minimally invasive gastrectomy (MIG) for malignancy is increasing. However, risk factors for conversion to open surgery during…”
Get full text

Gallbladder Cancer Incidentally Found at Cholecystectomy: Perioperative Risk Factors by Olecki, Elizabeth J., Mayhew, Mackenzie, Perez Holguin, Rolfy, Wong, William G., Stahl, Kelly A., Peng, June S., Dixon, Matthew E., Gusani, Niraj J.

“…Purpose Risk factors of gallbladder cancer (GBC) are not well-defined resulting in greater than 60% of GBCs being diagnosed incidentally following…”
Get full text

Pancreatoduodenectomy for monomorphic epitheliotropic intestinal T-cell lymphoma with duodenal obstruction by Olecki, Elizabeth J, Rakszawski, Kevin L, Peng, June S

“…We report an unusual case of a woman in her 60s diagnosed with monomorphic epitheliotropic intestinal T-cell lymphoma who required a pancreatoduodenectomy…”
Get full text

Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival by Olecki, Elizabeth J., Stahl, Kelly A., Torres, Madeline B., Peng, June S., Shen, Chan, Dixon, Matthew E.B., Gusani, Niraj J.

“…Background Clinical and pathologic staging determine treatment of pancreatic cancer. Clinical stage has been shown to underestimate final pathologic stage in…”
Get full text

Hidradeonoma Papilliferum of the Anus: A Case Report About the Relationship Between Neoplasms of the Mammary-Like-Glands and Hormones by Olecki, Elizabeth J, Scow, Jeffery S

“…Hidradenoma papilliferum (HP) is a benign pathologic finding that has been described primarily in the vulvar region. While thought to arise from ectopic tissue…”
Get full text